| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rose Chesworth, Howard Chi-Ho Yim, Georgia Watt, Emad El-Omar, Tim Kar. Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL/6JArc mice. Progress in neuro-psychopharmacology & biological psychiatry. 2024-04-22. PMID:38649130. |
a novel therapeutic candidate for cud, cannabidiol (cbd), can improve gut function in rodent models. |
2024-04-22 |
2024-04-26 |
mouse |
| Richard J Macatee, Mallory J Cannon, Brandon S Schermitzler, Thomas J Preston, Kaveh Afsha. Biological sex and hormonal contraceptive associations with drug cue reactivity in cannabis use disorder. Journal of psychiatric research. vol 174. 2024-04-16. PMID:38626562. |
biological sex differences in cannabis use disorder (cud) progression, cannabis withdrawal severity, and pharmacotherapy response have been reported, suggesting that cud mechanisms may differ by sex. |
2024-04-16 |
2024-04-19 |
Not clear |
| Richard J Macatee, Mallory J Cannon, Brandon S Schermitzler, Thomas J Preston, Kaveh Afsha. Biological sex and hormonal contraceptive associations with drug cue reactivity in cannabis use disorder. Journal of psychiatric research. vol 174. 2024-04-16. PMID:38626562. |
the aim of the present study was to test whether sex differences in neural cannabis cue reactivity and craving varied by female hc use in a cud sample. |
2024-04-16 |
2024-04-19 |
Not clear |
| Muhammad M Munir, Selamawit Woldesenbet, Yutaka Endo, Mary Dillhoff, Timothy M Pawli. Cannabis use disorder and perioperative outcomes following complex cancer surgery. Journal of surgical oncology. 2024-04-12. PMID:38606521. |
we sought to evaluate whether cannabis use disorder (cud) was associated with higher morbidity and mortality among patients undergoing complex cancer surgery. |
2024-04-12 |
2024-04-14 |
Not clear |
| Lidia Emmanuela Wiazowski Spelta, Caroline Cristiano Real, Vitor Bruno, Carlos Alberto Buchpiguel, Raphael Caio Tamborelli Garcia, Larissa Helena Torres, Daniele de Paula Faria, Tania Marcouraki. Impact of cannabidiol on brain glucose metabolism of C57Bl/6 male mice previously exposed to cocaine. Journal of neuroscience research. vol 102. issue 4. 2024-04-08. PMID:38588037. |
despite evidence of the beneficial effects of cannabidiol (cbd) in animal models of cocaine use disorder (cud), cbd neuronal mechanisms remain poorly understood. |
2024-04-08 |
2024-04-11 |
mouse |
| Carsten Hjorthøj, Anne Stürup, Mette Karlsen, Helene Speyer, Merete Osler, Dost Ongur, Merete Nordentof. Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study. Psychological medicine. 2024-04-04. PMID:38571303. |
we aimed to investigate whether use of antipsychotic medication, benzodiazepines, and psychiatric service use differs among patients with schizophrenia depending on whether psychosis was precipitated by a diagnosis of cannabis use disorder (cud). |
2024-04-04 |
2024-04-06 |
Not clear |
| Mohammad Ghafouri, Sabrina Correa da Costa, Ali Zare Dehnavi, Mark S Gold, Teresa A Rumman. Treatments for Cannabis Use Disorder across the Lifespan: A Systematic Review. Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539616. |
cannabis use disorder (cud) is a growing public health concern, with rising prevalence and significant impact on individuals across age groups. |
2024-03-28 |
2024-03-30 |
Not clear |
| Mohammad Ghafouri, Sabrina Correa da Costa, Ali Zare Dehnavi, Mark S Gold, Teresa A Rumman. Treatments for Cannabis Use Disorder across the Lifespan: A Systematic Review. Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539616. |
database searches were conducted for randomized controlled trials of cud interventions reporting outcomes such as cannabis use, abstinence, withdrawal symptoms, and treatment retention. |
2024-03-28 |
2024-03-30 |
Not clear |
| b' Alexander Denissoff, Heidi Taipale, Jari Tiihonen, Marta Di Forti, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Antti Mustonen, Solja Niemel\\xc3\\xa. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study. Schizophrenia bulletin. 2024-03-27. PMID:38534050.' |
there is a paucity of research on treatment outcomes of patients with psychosis and cannabis use disorder (cud). |
2024-03-27 |
2024-03-29 |
Not clear |
| Ardavan Mohammad Aghaei, Lia Urban Spillane, Brian Pittman, L Taylor Flynn, Joao P De Aquino, Anahita Bassir Nia, Mohini Ranganatha. Sex Differences in the Acute Effects of Oral THC: A Randomized, Placebo-Controlled, Crossover Human Laboratory Study. medRxiv : the preprint server for health sciences. 2024-03-19. PMID:38077095. |
recent reports have shown increased cannabis use among women, leading to growing concerns about cannabis use disorder (cud). |
2024-03-19 |
2024-03-21 |
human |
| Daniel Feingold, Dana Tzur Bitan, Marica Ferri, Eva Hoc. Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature. European archives of psychiatry and clinical neuroscience. 2024-03-17. PMID:38493284. |
treatment demand for cannabis use disorder (cud) has increased in the past decade in almost all european countries, and cud is currently the most common reason for first-time drug-related treatment admission in the european union. |
2024-03-17 |
2024-03-19 |
Not clear |
| Brittany Bass, Howard Padwa, Dhruv Khurana, Darren Urada, Anne Boustea. Adult use cannabis legalization and cannabis use disorder treatment in California, 2010-2021. Journal of substance use and addiction treatment. 2024-03-17. PMID:38494048. |
this paper contributes to knowledge of adult use legalization's associations with cannabis use disorder (cud) treatment utilization. |
2024-03-17 |
2024-03-20 |
Not clear |
| William Wang, Nora D Volkow, Nathan A Berger, Pamela B Davis, David C Kaelber, Rong X. Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study. Molecular psychiatry. 2024-03-15. PMID:38486046. |
cannabis is the most frequently used illicit drug in the united states with more than 45 million users of whom one-third suffer from a cannabis use disorder (cud). |
2024-03-15 |
2024-03-17 |
Not clear |
| Anna M Froude, Emily J Fawcett, Ashlee Coles, Dalainey H Drakes, Nick Harris, Jonathan M Fawcet. The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis. Journal of psychiatric research. vol 172. 2024-03-07. PMID:38452637. |
increased cannabis product accessibility and recent legislative changes have led to increased cannabis consumption, thereby increasing the risk of cannabis use disorder (cud). |
2024-03-07 |
2024-03-10 |
Not clear |
| Anjali K Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I Lubman, Peter Malouf, Mary E Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeri. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC psychiatry. vol 24. issue 1. 2024-03-03. PMID:38433233. |
cannabis use disorder (cud) is increasingly common and contributes to a range of health and social problems. |
2024-03-03 |
2024-03-06 |
Not clear |
| Anjali K Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I Lubman, Peter Malouf, Mary E Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeri. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC psychiatry. vol 24. issue 1. 2024-03-03. PMID:38433233. |
results from a phase iia randomised clinical trial suggest that treatment with cbd for four weeks reduced non-prescribed cannabis use in people with cud. |
2024-03-03 |
2024-03-06 |
Not clear |
| Alexander Beletsky, Cherry Liu, Bryson Lochte, Nebiyou Samuel, Igor Gran. Cannabis and Anxiety: A Critical Review. Medical cannabis and cannabinoids. vol 7. issue 1. 2024-02-26. PMID:38406383. |
the causal pathways and mechanisms underlying the association between cannabis use (cu)/cannabis use disorder (cud) and anxiety remain unclear. |
2024-02-26 |
2024-02-28 |
Not clear |
| Avilash Mondal, Sriharsha Dadana, Poojan Parmar, Maneeth Mylavarapu, Qiming Dong, Samia Rauf Butt, Abeera Kali, Bhaswanth Bollu, Rupak Desa. Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis. Medical sciences (Basel, Switzerland). vol 12. issue 1. 2024-02-23. PMID:38390863. |
we aimed to determine the risk of major adverse cardiac and cerebrovascular events (macce) in older non-tobacco smokers with established cvd risk with vs. without cannabis use disorder (cud). |
2024-02-23 |
2024-02-25 |
Not clear |
| Christal N Davis, John S Markowitz, Lindsay M Squeglia, Jarrod M Ellingson, Aimee L McRae-Clark, Kevin M Gray, Diana Kretschmer, Rachel L Tomk. Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis. Addictive behaviors. vol 153. 2024-02-23. PMID:38394959. |
early positive subjective effects of cannabis predict the development of cannabis use disorder (cud). |
2024-02-23 |
2024-02-26 |
human |
| Christal N Davis, John S Markowitz, Lindsay M Squeglia, Jarrod M Ellingson, Aimee L McRae-Clark, Kevin M Gray, Diana Kretschmer, Rachel L Tomk. Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis. Addictive behaviors. vol 153. 2024-02-23. PMID:38394959. |
young adults (n = 54) with cud or a non-cud substance use disorder (control) provided a blood sample for dna analysis and self-reported their early (i.e., effects upon initial uses) and past-year positive and negative subjective cannabis effects. |
2024-02-23 |
2024-02-26 |
human |